Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about ...
TRANSMEDICS (TMDX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
According to the lawsuit, throughout the Class Period, the Company and its senior executives misled investors and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, ...
Canaccord Genuity Group Reiterates “Buy” Rating for TransMedics Group (NASDAQ:TMDX)
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...
TMDX SHAREHOLDER NOTICE: TransMedics Group, Inc. Investors are Reminded to Contact BFA Law before the April 15 Class Action Deadline
New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Le Lézard1d
Shareholders that lost money on TransMedics Group, Inc.(TMDX) should contact The Gross Law Firm about pending Class Action - TMDX
The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...
The Motley Fool3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
TransMedics Group's organ care system can preserve multiple organs, but livers are responsible for 70% of total sales. OrganOx markets a normothermic machine perfusion device approved to preserve ...
Morningstar4d
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...
Nasdaq3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...
Le Lézard4d
TMDX INVESTOR DEADLINE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the ...
Morningstar6d
TMDX CLASS ACTION ALERT: TransMedics Group, Inc. is Being Sued in Connection with its Business Practices – Contact Robbins LLP for Information
SAN DIEGO, March 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics ...
TMDX CLASS ACTION ALERT: Transmedics Group, Inc. Is Being Sued In Connection With Its Business Practices – Contact Robbins LLP For Information
On this news, the price of TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to ...
Wall Street Journal1d
TransMedics Group Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...